Form 4: Hologic CFO Karleen Oberton Acquires 17,095 Shares

Hologic's Chief Financial Officer, Karleen Marie Oberton, reported the acquisition of 17,095 shares of common stock through performance stock units.

Summary

• Karleen Marie Oberton, Chief Financial Officer of Hologic Inc. (HOLX), acquired 17,095 shares of common stock.
• The transaction occurred on November 4, 2025.
• These shares represent performance stock units for which the performance criteria have been satisfied, but they remain subject to service-based vesting requirements.
• Performance stock units are settled in shares of common stock on a one-for-one basis.
• Following this transaction, Ms. Oberton beneficially owns a total of 119,203 shares of Hologic common stock.
• The total beneficial ownership includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.

Sentiment

Score: 6

Explanation: The acquisition of shares by a key executive, resulting from the satisfaction of performance criteria for stock units, generally indicates confidence in the company's performance and aligns executive interests with shareholders. However, as a routine compensation-related transaction, its direct impact on sentiment is moderate.

Positives

• The Chief Financial Officer, Karleen Marie Oberton, increased her direct beneficial ownership in Hologic Inc. by acquiring 17,095 shares of common stock.
• The acquisition stems from performance stock units, indicating that performance criteria have been met, which aligns management incentives with company success.

Negatives

• No negative information is disclosed in this Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing, which primarily reports an insider transaction.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance.

Management Comments

• No direct quotes or paraphrased statements from company management are included in this Form 4 filing.

Industry Context

This filing is a routine insider transaction report and does not provide broader industry context or trends. It reflects an individual executive's equity compensation and ownership within Hologic Inc.

Stakeholder Impact

• Shareholders: Potentially positive, as increased insider ownership can signal management's confidence in the company's future and better align executive incentives with shareholder interests.

Key Dates

Keywords

Hologic Inc., HOLX, Insider Transaction, Form 4, Karleen Marie Oberton, Chief Financial Officer, Performance Stock Units, Equity Acquisition, Beneficial Ownership